Search for: "Foley & Lardner" Results 261 - 280 of 1,103
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jun 2020, 9:56 pm by Patent Docs
District Court for the Western District of Texas, Eley Thompson of Foley & Lardner LLP, and Trenton Ward of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will discuss the speedy rise of the Western District of Texas as a litigation hotspot and important PTAB decisions about Section 314 that have gone some way to change the complex interaction between post-grant... [read post]
8 Feb 2013, 9:21 pm by Patent Docs
Stevens of Foley & Lardner will provide guidance for patent counsel on identifying and determining inventorship and will offer best practices for correcting errors regarding inventorship. [read post]
6 Jan 2018, 9:59 pm by Patent Docs
Patent and Trademark Office; Courtenay Brinckehoff of Foley & Lardner LLP; and Gary Ganzi, Senior Counsel and Head of Intellectual Property, Evoqua Water Technologies, LLC will discuss the regulation regarding declarations was promulgated by the USPTO through 37 C.F.R. [read post]
13 Jun 2014, 9:55 pm by Patent Docs
Dennis Crouch of the University of Missouri School of Law; Stephen Maebius of Foley & Lardner LLP, and Micky Minhas of Microsoft Corp. will help practitioners understand the bottom line for patent practice of this spring's two important appellate decisions addressing the standard for indefiniteness under § 112. [read post]
9 Jan 2011, 8:59 pm by Patent Docs
January 11, 2011 - Gene Patenting -- Defining a Potentially Pivotal Moment in Biotech (Foley & Lardner LLP) - 12:00 to 1:00 pm (EST) January 12, 2011 - New USPTO Guidelines and the Obviousness Standard for Patents (Strafford) - 1:00 - 2:30 PM (EST) January 21, 2011 - Patents, Innovation and Job Creation: A Virtuous Circle (Innovation Alliance) - Washington, DC January 25, 2011 - Understanding Obviousness in a Post-KSR World: Practical Applications for Compliance with the Recent… [read post]
9 Dec 2011, 9:45 pm by Patent Docs
The panel will include Courtenay Brinckerhoff of Foley & Lardner, Charles Doyle of Roche Molecular Systems, and Prof. [read post]
30 Jan 2021, 8:46 pm by Patent Docs
Houston of Foley & Lardner LLP, and Shaun Snader of United Therapeutics will discuss 2020's major developments at the Patent Trial and Appeal Board (PTAB) and how they may impact patent litigation practice going forward before the PTAB and beyond. [read post]
3 Jul 2014, 8:32 pm by Docket Navigator
  The top five firms in these post-grant proceedings are Finnegan, Fish & Richardson, Sterne Kessler, Foley & Lardner and Norton Rose Fulbright.The Patent Trial and Appeal Board has instituted more than 60 Covered Business Method Reviews and more than 500 Inter PartesReviews. [read post]
3 Feb 2018, 8:55 pm by Patent Docs
Greene's Energy Group, LLC" on February 8, 2018 from 5:30 to 8:00 pm (CT) at the offices of Foley & Lardner in Chicago, IL. [read post]
26 Mar 2013, 12:00 am by Doug Austin
During our recently concluded thought leader interview series, I had intended to line up at least one more interview – with Adam Losey, president and editor-in-chief of IT-Lex.org, a technology law not-for-profit educational and literary organization and an attorney at Foley & Lardner LLP. [read post]
21 May 2016, 8:41 pm by Patent Docs
Patent and Trademark Office, Courtenay Brinckerhoff of Foley & Lardner, and Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will probe deeply into the new examples published by the USPTO this month that show how claims for life science inventions should be examined by the agency for subject-matter patent eligibility. [read post]
29 Mar 2013, 9:55 pm by Patent Docs
A panel consisting of Jason Mudd of Erise IP, Matthew Smith of Foley & Lardner LLP, and Jeanne Suchodolski of Intellectual Ventures will analyze the Patent Trial and Appeals Board (PTAB) decisions since inter partes review (IPR) proceedings became available on September 16, 2012, and rely on their own experience to discuss: • How to get an IPR petition accepted? [read post]
23 May 2020, 7:40 pm by Patent Docs
.; Philip Hirschhorn of Panitch Schwarze Belisario & Nadel LLP; and Liane Peterson of Foley & Lardner LLP. [read post]
2 Jul 2021, 2:45 pm by Joe Patrice
Foley & Lardner matches... in 2022. [read post]
25 Mar 2013, 12:00 am by Doug Austin
During our recently concluded thought leader interview series, I had intended to line up at least one more interview – with Adam Losey, president and editor-in-chief of IT-Lex.org, a technology law not-for-profit educational and literary organization and an attorney at Foley & Lardner LLP. [read post]
17 Sep 2008, 4:54 am
Noonan -- Harold Wegner, dean of patent law cognoscenti and a partner at Foley & Lardner LLP in Washington, DC, regaled the audience at ACI's Biotech Patent Law conference on Monday with a talk on "Key Biotech Cases to Watch and How They May Impact Your Practice. [read post]
1 Dec 2018, 9:55 pm by Patent Docs
Tantleff of Foley & Lardner will guide counsel on negotiating and structuring joint development agreements (JDAs) to allocate IP ownership, and discuss the key provisions of the JDA to protect IP rights and avoid unintended consequences. [read post]
13 Jan 2012, 8:59 pm by Patent Docs
.; and Harold Wegner of Foley & Lardner, LLP will: • Give recommendations on how companies can restructure their invention disclosure and priority filing systems, including consideration of trade secret protection; • Consider how the new U.S. first-to-file system will be different than those that now exist internationally, and how those differences should be dealt with... [read post]
2 May 2020, 8:09 pm by Patent Docs
Ute Kilger of Boehmert & Boehmert will moderate a panel consisting of Robert DeBerardine of Johnson & Johnson, David Rosen of Foley & Lardner LLP, Corey Salsberg of Novartis, and Hans Sauer of the Biotechnology Innovation Organization (BIO). [read post]
5 Aug 2018, 9:52 pm by Patent Docs
Courtenay Brinckerhoff of Foley & Lardner LLP, Charles Chesney of Qualcomm Inc., and Roland McAndrews of Bookoff McAndrews PLLC will discuss potential pitfalls associated with U.S. provisional or CIP patent applications. [read post]